Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: a subgroup analysis of the PROLOGUE study
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 12
Abstract
Studies have shown that dipeptidyl peptidase-4 (DDP-4) inhibitors have anti-atherosclerotic effects. However, in the PROLOGUE study, sitagliptin failed to slow the progression of carotid intima-media thickness (CIMT) relative to conventional therapy. We conducted a post hoc analysis of the PROLOGUE study and compared the effects of sitagliptin and conventional therapy on changes in CIMT in subgroups with or without hyperuricemia. The PROLOGUE study was a randomized controlled trial of 442 patients with type 2 diabetes mellitus (T2DM). Patients were randomized to receive sitagliptin added therapy or conventional therapy. Based on the serum uric acid levels of all study populations in the PROLOGUE study, we divided them into hyperuricemia subgroup (n = 104) and non-hyperuricemia subgroup (n = 331). The primary outcome was changed in carotid intima-media thickness (CIMT) parameters compared with baseline during the 24 months treatment period. In the hyperuricemia subgroup, compared with the conventional therapy group, the changes in the mean internal carotid artery (ICA)-IMT and max ICA-IMT at 24 months were significantly lower in the sitagliptin group [−0.233 mm, 95% confidence interval (CI) (−0.419 to 0.046), p = 0.015 and −0.325 mm, 95% CI (−0.583 to −0.068), p = 0.014], although there was no significant difference in the common carotid artery CIMT. The results of our analysis indicated that sitagliptin attenuated the progression of CIMT than conventional therapy in T2DM and hyperuricemia patients.Keywords
Funding Information
- National Natural Science Foundation of China (31871182)
This publication has 59 references indexed in Scilit:
- The Value of Carotid Artery Plaque and Intima‐Media Thickness for Incident Cardiovascular Disease: The Multi‐Ethnic Study of AtherosclerosisJournal of the American Heart Association, 2013
- A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patientsMetabolism, 2013
- Combination of the Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients With Type 2 DiabetesDiabetes Care, 2011
- Associations of cardiovascular risk factors, carotid intima-media thickness and left ventricular mass with inter-adventitial diameters of the common carotid artery: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2011
- Carotid-Wall Intima–Media Thickness and Cardiovascular EventsNew England Journal of Medicine, 2011
- Relationship of oxidized low density lipoprotein with lipid profile and oxidative stress markers in healthy young adults: a translational studyLipids in Health and Disease, 2011
- Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney DiseaseAmerican Journal of Nephrology, 2011
- Effect of Serum Insulin on the Association Between Hyperuricemia and Incident Heart FailureThe American Journal of Cardiology, 2010
- Association between hyperuricemia and incident heart failure among older adults: A propensity-matched studyInternational Journal of Cardiology, 2010
- Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility studyCardiovascular Diabetology, 2010